Genetics of obesity and obesity-related hypertension

被引:9
|
作者
Hamann, A
Sharma, AM
机构
[1] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany
[2] Humboldt Univ, Franz Volhard Clin, Charite, D-1086 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
关键词
D O I
10.1053/snep.2002.30208
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Obesity results from an imbalance between caloric intake and energy expenditure. Twin, adoption, and family studies have not only shown that genetic factors play an important role in the pathogenesis of obesity, but also contribute to several comorbidities including hypertension and type 2 diabetes. In recent years, several single-gene defects responsible for obesity in rodents and, in rare cases, of human obesity have been identified. Besides leptin as the most notable example, numerous other proteins and neuropeptides have recently been found that participate in a complex network to regulate food intake and energy expenditure. Interestingly, some of these molecules may also play a role in the development of obesity-related hypertension. The ongoing search for relevant genetic variants should result in a better understanding of energy metabolism and hopefully clarify molecular mechanisms underlying the association between obesity and related comorbidities. This knowledge should help develop new strategies for the treatment of obesity and associated risk factors for hypertension and related cardiovascular disorders.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 50 条
  • [41] THE ZUCKER RAT AS A MODEL OF OBESITY-RELATED HYPERTENSION
    KURTZ, TW
    MORRIS, RC
    PERSHADSINGH, HA
    HYPERTENSION, 1988, 12 (03) : 354 - 354
  • [42] Mechanisms of sympathetic activation in obesity-related hypertension
    Esler, Murray
    Straznicky, Nora
    Eikelis, Nina
    Masuo, Kazuko
    Lambert, Gavin
    Lambert, Elisabeth
    HYPERTENSION, 2006, 48 (05) : 787 - 796
  • [43] Hyperleptinemia as a risk factor in obesity-related hypertension
    Alvarez-Aguilar, C
    Mondragón-Jiménez, LI
    Ramírez-Enríquez, J
    Gómez-García, A
    Paniagua-Sierra, R
    Amato, D
    MEDICINA CLINICA, 2004, 123 (20): : 766 - 769
  • [44] Highlights of mechanisms and treatment of obesity-related hypertension
    Elham Shams
    Vijayvardhan Kamalumpundi
    Joshua Peterson
    Ronaldo Altenburg Gismondi
    Wille Oigman
    Marcelo Lima de Gusmão Correia
    Journal of Human Hypertension, 2022, 36 : 785 - 793
  • [45] Pathophysiological role of leptin in obesity-related hypertension
    Aizawa-Abe, M
    Ogawa, Y
    Masuzaki, H
    Ebihara, K
    Satoh, N
    Iwai, H
    Matsuoka, N
    Hayashi, T
    Hosoda, K
    Inoue, G
    Yoshimasa, Y
    Nakao, K
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09): : 1243 - 1252
  • [46] Obesity and obesity-related comorbidities research
    Burton, D
    JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2004, 41 (04): : 641 - 641
  • [47] Sympathoinhibitory signals from the gut and obesity-related hypertension
    Daniela M. Sartor
    Clinical Autonomic Research, 2013, 23 : 33 - 39
  • [48] PATHOPHYSIOLOGY AND TREATMENT OF THE OBESITY-RELATED ARTERIAL-HYPERTENSION
    KOLANOWSKI, J
    ACTA CLINICA BELGICA, 1992, 47 : 18 - 25
  • [49] Obesity-related hypertension: Is there a role for selective leptin resistance?
    Correia, MLG
    Haynes, WG
    CURRENT HYPERTENSION REPORTS, 2004, 6 (03) : 230 - 235
  • [50] Obesity-related hypertension: Is there a role for selective leptin resistance?
    Marcelo L. G. Correia
    William G. Haynes
    Current Hypertension Reports, 2004, 6 : 230 - 235